v3.25.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Operating activities:      
Net income (loss) from continuing operations $ (1,124,841) $ 42,803 $ 179,414
Adjustments to reconcile net income (loss) of continuing operations to net cash provided by operating activities of continuing operations:      
Depreciation and amortization 143,978 57,405 42,552
Impairment of goodwill 1,028,397 0 0
Change in fair value of earn-out liability 0 0 (294)
Share-based compensation expense 10,188 11,495 10,661
Provision for revenue adjustments 3,635 5,091 6,426
Deferred income tax expense (benefit) (133,510) (8,893) 7,686
Other 14,917 (1,180) (1,279)
Changes in operating assets and liabilities, net of effects from the purchase of acquired companies:      
Accounts receivable 9,546 30,555 (2,588)
Other receivables 9,677 (5,408) 8,097
Other current and noncurrent assets (15,085) 30,683 (13,280)
Accounts payable and accrued expenses (15,917) 36,661 12,766
Net cash (used in) provided by operating activities of continuing operations (69,015) 199,212 250,161
Investing activities:      
Proceeds from sale of property and equipment 5,137 3,741 2,372
Purchases of property and equipment (37,060) (30,725) (39,254)
Purchase of businesses, net of cash acquired (1,576,219) (56,703) (66,105)
Other (444) 0 0
Net cash used in investing activities of continuing operations (1,608,586) (83,687) (102,987)
Financing activities:      
Repayments of finance lease obligations (18,425) (9,500) (6,108)
Proceeds from credit facility 75,000 70,000 0
Payments on credit facility (155,000) (178,500) (49,000)
Proceeds from long-term debt held in escrow 0 1,790,500 0
Payment of debt issuance costs (52,471) 0 0
Proceeds from issuance of common stock upon stock option exercises 0 0 206
Payment of earn-out liability (12,247) 0 (91)
Payments of dividends to shareholders 0 (24,995) (25,865)
Repurchases and retirement of common stock 0 (93,811) (62,771)
Proceeds from common stock issued under employee stock purchase plan 753 800 783
Payment of minimum tax withholdings on share-based awards (1,442) (4,340) (3,330)
Contributions from subsidiary held for sale 0 240,572 7,508
Net cash provided by (used in) financing activities of continuing operations (163,832) 1,790,726 (138,668)
Effect of exchange rate changes on cash 1,013 0 0
Net (decrease) increase in cash, cash equivalents and restricted cash equivalents from continuing operations (1,840,420) 1,906,251 8,506
Cash from discontinued operation:      
Net (used in) cash provided by operating activities of discontinued operations (6,387) (17,824) 8,929
Net cash provided by (used in) investing activities of discontinued operations 0 258,525 (1,475)
Net cash used in financing activities of discontinued operations 0 (240,701) (7,454)
Net (decrease) increase in cash, cash equivalents and restricted cash equivalents (1,846,807) 1,906,251 8,506
Cash, cash equivalents, and restricted cash equivalents at beginning of period of continuing operations 1,952,073 45,822 37,316
Cash at beginning of period of discontinued operations 0 0 0
Cash, cash equivalents, and restricted cash equivalents at end of period of continuing operations 105,266 1,952,073 45,822
Reconciliation of cash, cash equivalents, and restricted cash equivalents:      
Cash and cash equivalents 104,903 121,969 45,822
Restricted cash equivalents 363 39,604 0
Noncurrent restricted cash equivalents 0 1,790,500 0
Total cash, cash equivalents, and restricted cash equivalents shown in the statement of cash flow: $ 105,266 1,952,073 45,822
Non-cash activity:      
Equipment acquired under finance leases   $ 25,217 $ 14,422

Source